Brasilicardin A, a new terpenoid antibiotic from pathogenic Nocardia brasiliensis: fermentation, isolation and biological activity

J Antibiot (Tokyo). 1999 Jan;52(1):13-9. doi: 10.7164/antibiotics.52.13.

Abstract

A novel tricyclic diterpenoid antibiotic, brasilicardin A, was isolated from the culture broth of Nocardia brasiliensis IFM 0406. The antibiotic exhibited immunosuppressive activity in a mouse mixed lymphocyte reaction (MLR) assay system and its IC50 value was 0.057 microg/ml. Although the inhibitory activity of cyclosporin A (CyA) against IL-2 production was confirmed in the MLR assay system, brasilicardin A did not have the activity. The results of in vitro toxicity testing of brasilicardin A against various human cell lines were compared with those of CyA.

MeSH terms

  • Aminoglycosides*
  • Animals
  • Anti-Bacterial Agents / biosynthesis
  • Anti-Bacterial Agents / isolation & purification
  • Anti-Bacterial Agents / pharmacology*
  • Bacteria / drug effects
  • Cell Survival / drug effects
  • Cells, Cultured
  • Chromatography, High Pressure Liquid
  • Fermentation
  • Fungi / drug effects
  • Humans
  • Immunophilins / antagonists & inhibitors
  • Immunosuppressive Agents / isolation & purification
  • Immunosuppressive Agents / pharmacology*
  • Interleukin-2 / metabolism
  • Lymphocyte Culture Test, Mixed
  • Mice
  • Microbial Sensitivity Tests
  • Nocardia / metabolism*

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Immunosuppressive Agents
  • Interleukin-2
  • brasilicardin A
  • Immunophilins